PLoS Medicine (Sep 2017)

Sustained effectiveness and cost-effectiveness of the Healthy Activity Programme, a brief psychological treatment for depression delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial.

  • Benedict Weobong,
  • Helen A Weiss,
  • David McDaid,
  • Daisy R Singla,
  • Steven D Hollon,
  • Abhijit Nadkarni,
  • A-La Park,
  • Bhargav Bhat,
  • Basavraj Katti,
  • Arpita Anand,
  • Sona Dimidjian,
  • Ricardo Araya,
  • Michael King,
  • Lakshmi Vijayakumar,
  • G Terence Wilson,
  • Richard Velleman,
  • Betty R Kirkwood,
  • Christopher G Fairburn,
  • Vikram Patel

DOI
https://doi.org/10.1371/journal.pmed.1002385
Journal volume & issue
Vol. 14, no. 9
p. e1002385

Abstract

Read online

BackgroundThe Healthy Activity Programme (HAP), a brief behavioural intervention delivered by lay counsellors, enhanced remission over 3 months among primary care attendees with depression in peri-urban and rural settings in India. We evaluated the sustainability of the effects after treatment termination, the cost-effectiveness of HAP over 12 months, and the effects of the hypothesized mediator of activation on clinical outcomes.Methods and findingsPrimary care attendees aged 18-65 years screened with moderately severe to severe depression on the Patient Health Questionnaire 9 (PHQ-9) were randomised to either HAP plus enhanced usual care (EUC) (n = 247) or EUC alone (n = 248), of whom 95% completed assessments at 3 months, and 91% at 12 months. Primary outcomes were severity on the Beck Depression Inventory-II (BDI-II) and remission on the PHQ-9. HAP participants maintained the gains they showed at the end of treatment through the 12-month follow-up (difference in mean BDI-II score between 3 and 12 months = -0.34; 95% CI -2.37, 1.69; p = 0.74), with lower symptom severity scores than participants who received EUC alone (adjusted mean difference in BDI-II score = -4.45; 95% CI -7.26, -1.63; p = 0.002) and higher rates of remission (adjusted prevalence ratio [aPR] = 1.36; 95% CI 1.15, 1.61; p ConclusionsHAP's superiority over EUC at the end of treatment was largely stable over time and was mediated by patient activation. HAP provides better outcomes at lower costs from a perspective covering publicly funded healthcare services and productivity impacts on patients and their families.Trial registrationISRCTN registry ISRCTN95149997.